Facebook PamLampitt.com

Lampitt & Greenwald Resolution Condemning Global Acts of Anti-Semitism Approved by Assembly

Assembly Majority Office
June 11, 2015
Link to original

(TRENTON) -- Legislation Assemblywoman Pamela Rosen Lampitt, Assembly Majority Leader Louis Greenwald and Assemblymen Vince Mazzeo, Gary Schaer, Joseph Lagana, and Tim Eustace sponsored condemning global acts of Anti-Semitism and calling for expansion of Holocaust education programs to combat prejudice was approved 74-0Thursday by the Assembly.

The resolution (ACR-211) was previously advanced by the Assembly State and Local Government Committee.

"We have seen a rising tide of disturbing anti-Semitic acts across the globe in recent years. Whether it is the vandalizing of houses of worship, attacks on families or the disgusting pronouncements of Holocaust-deniers, these acts deserve our strongest outrage and condemnation." said Lampitt (D-Camden/Burlington) "This virulent strain of prejudice is an affront to the very notions of humanity that form the center of any civilized society."

"Throughout history, the Jewish people have endured horrific and unrelenting persecution because of their religion," said Greenwald (D-Camden/Burlington). "Anti-Semitism has no place in our state, in our nation or in our world. It is the duty of leaders in public service to stand up and speak out against this unacceptable prejudice."

Lampitt Bill to Make Cost-Effective Biological Drug Alternatives More Widely Available

Assembly Majority Office
June 8, 2015
Link to original

A Senate panel on Monday continued advancing legislation sponsored by Assembly Democrats Pamela Lampitt, Herb Conaway, Jr., M.D., Daniel Benson, Shavonda Sumter, Angel Fuentes and Nancy Pinkin to make it easier for consumers to obtain more cost-effective, "generic" versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer.

"The FDA has created a safe pathway to make alternative biological medicines more readily available on the market," said Lampitt (D-Camden/Burlington). "If there is a more cost-effective option to treat and cure various illnesses, then by all means we should be helping patients pursue it."

"Substitution of these biologically similar products for their name-brand counterparts at the pharmacy level is expected to reduce cost by increasing competition," said Conaway (D-Burlington). "Ultimately, this will allow more patients to access treatments."

While New Jersey has allowed chemically-synthesized generic drugs to be substituted for brand-name prescriptions for quite some time because the active ingredients are identical to their brand-name counterparts, biological medicines, on the other hand, are manufactured through biotechnology using living organisms and are much more complex than traditional, chemically-synthesized drugs.

Lampitt Measures to Support Parents Pursuing Higher Education Gain Assembly Panel Approval

Assembly Majority Office
June 4, 2015
Link to original

Legislation sponsored by Assemblywomen Pamela Lampitt, Mila Jasey and Marlene Caride to help ensure that parents pursuing higher education in New Jersey have access to the services and accommodations they need was advanced by an Assembly panel on Thursday.

"Women who are pregnant or have children - many of whom also work - face unique challenges as they pursue their education that their professors and peers may not even realize limit their capacity to succeed," said Lampitt (D-Camden/Burlington). "These bills will make it easier for parents to earn a degree so that they can better provide for their children."

"Too often, parents who want to seek out the qualifications that will make them more marketable to employers find that difficulties in finding adequate child care or taking time off from coursework put them at an academic disadvantage," said Jasey (D-Essex/Morris). "This legislation is about making sure that students with children don't feel that they have to compromise their studies in order to care for their families."

Lampitt Bill to Promote Flu Vaccination Awareness Among Seniors Continues Advancing

May 18, 2015

Legislation sponsored by Assembly Democrats Pamela Lampitt, Joseph Lagana, Angelica Jimenez, Tim Eustace and Vince Mazzeo to promote seasonal influenza awareness among New Jersey seniors was approved by the Senate on Monday.

The bill (A-3890) would require the Department of Health to prepare and publish online printer-friendly information about the flu vaccine for older adults.

"Older New Jerseyans are far more susceptible to serious flu-related complications. Because their immune systems are weaker, the flu can result in hospitalization or even death among seniors," said Lampitt (D-Camden/Burlington). "Supplying members of this specific population with the information they need to protect themselves and those around them can keep older residents healthy and save lives."

The information would include items such as:
- How vaccination can help prevent the flu in older adults;
- The availability and efficacy of the flu vaccine for older adults;
- A recommendation that seniors consult with their physicians regarding the flu vaccine; and
- The particular individual and community benefits of vaccination among older adults sharing close quarters, such as residents of continuing care retirement communities (CCRCs)

Each CCRC in New Jersey would be required to post the information in a conspicuous public place in the facility no later than August 1 of each year. The provisions of the bill, however, do not require seniors to receive a flu vaccination, the sponsored noted.

Assembly Approved Bill to Make Cost-Effective Biological Drug Alternatives More Widely Available

May 14, 2015

The full Assembly on Thursday unanimously approved legislation sponsored by Assembly Democrats Pamela Lampitt, Herb Conaway, Jr., M.D., Daniel Benson, Shavonda Sumter, Angel Fuentes and Nancy Pinkin to make it easier for consumers to obtain more cost-effective, "generic" versions of biological medicines used to treat conditions such as rheumatoid arthritis, anemia, psoriasis and various forms of cancer.

"The FDA has created a safe pathway to make alternative biological medicines more readily available on the market," said Lampitt (D-Camden/Burlington). "If there is a more cost-effective option to treat and cure various illnesses, then by all means we should be helping patients pursue it."

"Substitution of these biologically similar products for their name-brand counterparts at the pharmacy level is expected to reduce cost by increasing competition," said Conaway (D-Burlington). "Ultimately, this will allow more patients to access treatments."

While New Jersey has allowed chemically-synthesized generic drugs to be substituted for brand-name prescriptions for quite some time because the active ingredients are identical to their brand-name counterparts, biological medicines, on the other hand, are manufactured through biotechnology using living organisms and are much more complex than traditional, chemically-synthesized drugs.